Physician profile
Logan W Murphy
NPI 1659785442
$1,225.94
in general payments reported to CMS, 2019-2025
18 companies · $91.42 in 2025
The $91.42 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $78.14 · 2021: $85.31 · 2022: $656 · 2023: $140 · 2024: $175 · 2025: $91.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $406.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $450.43 | 2022 | |
| Pfizer INC. | $94.10 | 2023-2025 | |
| Abbvie INC. | $91.75 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $84.64 | 2022 | |
| Novo Nordisk INC | $78.61 | 2020-2024 | Rybelsus, Ozempic |
| Shield Therapeutics INC | $65.45 | 2024 | |
| Merck Sharp & Dohme LLC | $54.51 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.15 | 2022-2024 | Xifaxan |
| Lilly USA, LLC | $49.55 | 2020-2024 | Mounjaro, Zepbound |
| Daiichi Sankyo INC. | $34.76 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $31.24 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $27.95 | 2024 | Airsupra, Breztri |
| Glaxosmithkline, LLC. | $27.53 | 2022-2023 | Trelegy Ellipta |
| Vanda Pharmaceuticals INC. | $19.03 | 2025 | Hetlioz, Fanapt |
| Exact Sciences Corporation | $17.57 | 2025 | Cologuard Collection Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $17.52 | 2023 | |
| Hologic Sales and Service, LLC | $15.83 | 2022 | |
| Exeltis, USA INC. | $11.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Logan Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.